Delivery Order SPE2DB20D2014-SPE2DB26FA23B
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Solu-Medrol 125 mg vials, with a ceiling value of $1,441.31. This non-competitive delivery order, which was awarded on October 24, 2025, with an ultimate completion date of October 27, 2025, utilizes firm fixed-price pricing. The place of performance is located at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,719.96 to AmerisourceBergen Drug Corp for the supply of Solu-Medrol 125 mg vials. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of October 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same city. This delivery order represents a task...
- The Defense Logistics Agency awarded a delivery order valued at $2,017.32 to AmerisourceBergen Drug Corp for the supply of Solu-Medrol 125 mg vials. This firm fixed-price delivery order, awarded on October 27, 2025, was issued without a set-aside designation, indicating it was awarded through open competition. The order is scheduled for completion by October 28, 2025, with fulfillment performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Solu-Medrol 1 gram vials, with a ceiling value of $3,636.56. This is a firm fixed price delivery order with no set-aside designation, utilizing open competition. The order is scheduled for completion by August 6, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Solu-Medrol 40 mg vials valued at $5,223.67 with a firm fixed price structure. The contract, with an ultimate completion date of August 8, 2025, represents a competitively awarded, non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,127.81 to AmerisourceBergen Drug Corp for the supply of Solu-Medrol 125 mg vials. This firm fixed price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 14, 2025. The award fulfills pharmaceutical supply requirements with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for SOLU-MEDROL 1 gram vials valued at $3,330.42. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 6, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary operations. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order valued at $1,265.88 by the Defense Logistics Agency's Medical Supply Chain on August 22, 2025, for the supply of Solu-Medrol 500 mg vials. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 25, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,292.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Solu-Medrol 125mg in quantities of 25 units. The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of July 16, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,482.27 firm fixed-price delivery order is for the supply of SOLU-MEDROL 125 MG vials, a specialty medication. The contract has an ultimate completion date of December 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB26FA23BDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,083.44 to AmerisourceBergen Drug Corp for the supply of Solu-Medrol 125 mg vials. This non-competitive, firm fixed-price delivery order was awarded on October 30, 2025, with an ultimate completion date of October 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Solu-Medrol (methylprednisolone sodium succinate) is a corticosteroid used in military and federal healthcare settings for treating inflammation and immune-related conditions. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement valued through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a broad range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs globally. The parent IDC represents part of DLA's Pharmaceutical Prime Vendor Global Program, which strategically utilizes multiple contractors to ensure reliable pharmaceutical supply chain support for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/30/25 |